U.S., Oct. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07222748) titled 'A Phase 3 Study on TLC590 for Managing Postsurgical Pain Following Bunionectomy' on Oct. 28.
Brief Summary: This is a Phase 3, randomized, double-blind, comparator- and placebo-controlled study to evaluate analgesic efficacy and safety of TLC590 via local infiltration in adult subjects following bunionectomy.
Study Start Date: Nov., 2025
Study Type: INTERVENTIONAL
Condition:
Postoperative Pain
Intervention:
DRUG: TLC590
TLC590 (Ropivacaine Extended-Release Injectable Suspension)
DRUG: Bupivacaine
Bupivacaine Liposome Injectable Suspension
DRUG: Saline Placebo
Normal Saline 0.9%
Recruitment Status: NOT_YET_RECRUITING
Spo...